Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02625220 · ClinicalTrials.gov registry record · NA
Dispensing Evaluation of Investigational Contact Lenses
A NA study of Myopia; Astigmatism, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 177
- Enrollment target
- 12
- Study locations
NCT02625220 is a NA study of Myopia; Astigmatism that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 177 participants. The trial reports 12 study locations across 9 states.
The verdict
NCT02625220, a NA study of Myopia; Astigmatism, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 177 participants
- Enrollment target
- 12
- Study locations
Study Summary
Non-randomized, single-masked, 2-visit, bilateral wear, single-arm dispensing study to evaluate the visual acuity, rotational performance, lens fit, stability and subjective characteristics of a senofilcon-based JJVCI investigational toric contact lens design.
Conditions Studied
Interventions
- DEVICE Prototype toric lens senofilcon A
Study Locations (12)
Florida
- Edward S. Wygonik, OD - Jacksonville
- The Eye Center - Pembroke Pines
- Eye Associates of Winter Park - Winter Park
Ohio
- New Image Eye Center - Springfield
- Professional Vision Care - Westerville
Illinois
- Eyecare Associates - Bloomington
Indiana
- Indiana University College of Optometry - Bloomington
Kansas
- Kannarr Eye Care - Pittsburg
New Mexico
- ABQ Eyecare - Albuquerque
New York
- Sacco Eye Group - Vestal
Rhode Island
- West Bay Eye Associates - Warwick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2015-10 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02625220
The ClinicalTrials.gov registry entry for NCT02625220 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myopia; Astigmatism appearing as the primary indexed condition, and to 1 intervention - of which Prototype toric lens senofilcon A is the first listed.
NCT02625220 reports 12 study locations spanning 9 distinct geographic areas - top geographies include Florida, Ohio, Illinois.
Frequently Asked Questions
What is clinical trial NCT02625220 about?
NCT02625220 is a clinical study titled "Dispensing Evaluation of Investigational Contact Lenses". Non-randomized, single-masked, 2-visit, bilateral wear, single-arm dispensing study to evaluate the visual acuity, rotational performance, lens fit, stability and subjective characteristics of a senofilcon-based JJVCI investigational toric contact lens design.
What is the current status of trial NCT02625220?
This trial is currently completed. It is a NA study. The enrollment target is 177 participants. The study started on 2015-10. Estimated completion is 2015-11.
What conditions does trial NCT02625220 study?
This clinical trial studies the following conditions: Myopia; Astigmatism.
What interventions are being tested in trial NCT02625220?
The interventions under investigation include: Prototype toric lens senofilcon A (DEVICE).
Who is sponsoring clinical trial NCT02625220?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02625220 being conducted?
This trial has 12 study locations across Florida, Illinois, Indiana, Kansas, New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.